Pharm 52: Adrenocorticosteroids

About this set

Created by:

lcoghill  on November 10, 2011

Subjects:

Pharmacology

Log in to favorite or report as inappropriate.
Pop out
No Messages

You must log in to discuss this set.

Pharm 52: Adrenocorticosteroids

Beclomethasone
MOA: Short acting synthetic glucocorticoid (10h) -> used aerosol, penetrates airway mucosa (low systemic toxicity)

USE: Asthma
1/14

Study:

Cards (new!)

Learn

Test

Speller

Scatter

Games:

Scatter

Space Race

Tools:

Export

Copy

Combine

Embed

Order by

Terms

Definitions

Beclomethasone MOA: Short acting synthetic glucocorticoid (10h) -> used aerosol, penetrates airway mucosa (low systemic toxicity)

USE: Asthma
Methylprednisone, Prednisone (prodrug), Triamcinolone, Fluticasone MOA: Synthetic glucocorticoids -> intermediate acting (24h)

USE: CAH (21 hydroxylase def), inflammation, Anti-emetic, Hodgkins (prodrug), fetal lung maturity (IM), hematologic disorders, organ transplants (prevent rejection), renal disorders (nephrotic syndrome), hypercalcemia, mountain sickness, IBD
Hydrocortisone (Cortisol)MOA: Naturally occurring glucocorticoid -> short duration of action (10h), diffuses poorly across skin unless inflamed, well across mucous membranes -> some salt retaining effects

USE: #1 for Addison's (with fludrocortisone), #1 for acute adrenal insufficiency (parenteral), CAH (21 hydroxylase def), inflammation, fetal lung maturation, before and after surgery for Cushing's, stress dose for pts with adrenal insufficiency during serious illness or prior to surgery
Dexamethasone MOA: long acting glucocorticoid (2 days)

USE: potent anti-inflammatory action, #1 cerebral edema, CAH (21 hydroxylase def, protect fetus in high risk pregnancies by administration to mother), fetal lung maturation
*used as a diagnostic tool for Cushing's syndrome, depressive psychiatric states

AE: not used in Addison's
Aldosterone, Fludrocortisone MOA: mineralocorticoids -> bind intracellular receptor and cause increased expression Na/K/ATPase and ENaC -> promote Na reabsorption from renal tubule, promote K+ and H+ excretion -> Salt-retaining hormones

USE: Addison's, adrenal insufficiency (once stabilized), CAH (once stabilized)
Mifepristone MOA: Glucocorticoid and progesterone antagonist

USE: inoperable pts with ectopic ACTH syndrome (Cushing's) or adrenal carcinoma
Spironolactone MOA: Mineralocorticoid antagonist - competitive inhibitor

USE: aldosteronism (diagnosis and treament), hirsutism in women (acts as androgen antagonist), diuretic

AE: Hyperkalemia*, cardiac arrhythmia, menstrual abnormalities, gynecomastia, sedation, headache, GI disturbances, skin rash
Ketoconazole MOA: Corticosteroid Synthesis inhibitor -> potent and non-selective inhibitor of adrenal and gonadal steroid synthesis

USE: Cushing's syndrome, prostate cancer
Aminoglutethimide MOA: Corticosteroid Synthesis inhibitor -> blocks conversion of cholesterol to pregnenolone (desmolase)

USE: Adrenal cancer (add hydrocortisone or dexamethasone)
Metyrapone MOA: Corticosteroid synthesis inhibitor -> selective inhibitor of 11-hydroxylation -> interferes with cortisol and corticosterone synthesis

USE: tests adrenal function, treat pregnant women with Cushing's

AE: salt and water retention, Hirsutism, transient dizziness, GI disturbances
Metabolic/Catabolic effects of glucocorticoidsSteroid receptor complex enters nucleus and increases txn producing tissue specific responses
Metabolic effects maintain adequate glucose supply to brain -> central fat redistribution, hyperglycemia -> Cushing's
Catabolic effects (proteins, lymphoid, CT, muscle, peripheral fat and skin, bone) cause osteoporosis (give Ca and Vit D supplements), peripheral fat wasting and growth retardation in children, myopathy
Anti-inflammatory and immunosuppressive effects of glucocorticoids increased neutrophils, decreased lymphocytes, inhibit PLA2/COX-2/PG, vasoconstriction due to suppression of mast cell degranulation
Peptic ulcers (stimulation of gastric acid and suppression of immune response to H. pylori)
Other effects of glucocorticoidsCNS = behavioural changes (insomnia, euphoria leading to depression), increased ICP and intraocular pressure (glaucoma), cataracts
Suppression of release of ACTH, GH, TSH, LH with chronic use
Increased platelets and RBCs
Deficiency causes renal impairment
Development of fetal lungs
sodium and fluid retention, loss of potassium -> give K+ supplement
Adrenal suppression with abrupt withdrawal (taper dose)
Glucocorticoid contraindications peptic ulcers
heart disease/HTN with heart failure
TB/VZV infections
Psychoses
Diabetes
Osteoporosis
Glaucoma

First Time Here?

Welcome to Quizlet, a fun, free place to study. Try these flashcards, find others to study, or make your own.

Set Champions

There are no high scores or champions for this set yet. You can sign up or log in to be the first!